Evidence map›Paper›PMID 41484277›Full record

ArticleCommunications biology2026

Canine parvovirus infection affects host cell nucleolar organization and ribosome biogenesis.

Moona Huttunen, Satu Hakanen, Vesa Aho, Simon Leclerc, Aynur Soenmez, Sergey Kapishnikov, Alessandro Zannotti, Visa Ruokolainen, Kari Salokas, Markku Varjosalo and 6 more

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Moona Huttunen *Department of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland.
Satu Hakanen *Department of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland.
Vesa AhoDepartment of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland.ORCID http://orcid.org/0000-0003-3142-2452
Simon LeclercDepartment of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland.ORCID http://orcid.org/0000-0003-1611-7572
Aynur SoenmezRNA Molecular Biology, Fonds de la Recherche Scientifique (F.R.S./FNRS), Biopark campus, Université libre de Bruxelles (ULB), B-Gosselies, Bruxelles, Belgium.
Sergey KapishnikovSiriusXT Limited, Dublin, Ireland.ORCID http://orcid.org/0000-0003-2560-054X
Alessandro ZannottiSiriusXT Limited, Dublin, Ireland.
Visa RuokolainenDepartment of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland.ORCID http://orcid.org/0000-0001-6805-0336
Kari SalokasInstitute of Biotechnology and Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-4471-6698
Markku VarjosaloInstitute of Biotechnology and Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-1340-9732
Leena LatonenInstitute of Biomedicine, University of Eastern Finland, Kuopio, Finland.ORCID http://orcid.org/0000-0003-4502-2193
Colin R ParrishBaker Institute for Animal Health, Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.ORCID http://orcid.org/0000-0002-1836-6655
Kenneth FahySiriusXT Limited, Dublin, Ireland.
Salla MattolaDepartment of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland.
Denis L J Lafontaine *RNA Molecular Biology, Fonds de la Recherche Scientifique (F.R.S./FNRS), Biopark campus, Université libre de Bruxelles (ULB), B-Gosselies, Bruxelles, Belgium. denis.lafontaine@ulb.be.ORCID http://orcid.org/0000-0001-7295-6288
Maija Vihinen-Ranta *Department of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland. maija.vihinen-ranta@jyu.fi.ORCID http://orcid.org/0000-0003-0959-1153

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101017116
6 · The paper itself

Abstract

The nucleolus is a biomolecular condensate essential for ribosome biogenesis and cellular stress response, and it is a key target for many DNA viruses. However, little is known about how autonomous parvovirus infection impacts the nucleolus. Here, we used ten-fold robust expansion microscopy, cryo soft X-ray tomography, interactomics, and biochemical approaches to study nucleolar remodeling during canine parvovirus infection. The nucleolus is organised in nested layers. Infection led to redistribution of nucleolar upstream binding transcription factor 1 (inner core), fibrillarin (middle layer), and Ki-67 (outer rim). In contrast, peripheral nucleolar proteins (nucleolin and nucleophosmin) and precursor ribosomal RNAs remain in spherical structures. High-resolution microscopy revealed profound nucleolar structural changes, including thickened perinucleolar chromatin and enlarged nucleolar low-protein density channels. BioID identified interactions between viral NS2 and nucleolar proteins involved in ribosome biogenesis. Northern blotting demonstrated a slowdown in ribosome biogenesis during infection. Collectively, these findings provide insights into how parvoviruses remodel nucleolar structure and function.

Indexed as

Cell NucleolusParvoviridae InfectionsParvovirus, CanineRibosomesAnimalsChromosomal Proteins, Non-HistoneDogsHumansNuclear ProteinsNucleophosminOrganelle BiogenesisChromosomal Proteins, Non-HistonefibrillarinNuclear ProteinsNucleophosmin

Identifiers

PMID41484277
PMCPMC12764886

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.